ASSOCIATION ORAL CORTICOSTEROIDS AND LONG-TERM RISK OF CATARACT: A SYSTEMATIC REVIEW AND META-ANALYSIS STUDY
DOI:
https://doi.org/10.61841/tpn62p53Keywords:
Cataract, oral corticosteroidsAbstract
Background: Cataracts are a significant health concern, particularly in aging populations, impacting vision, mental well-being, and overall quality of life. Corticosteroid use has been linked to cataract development. This study aims to explore the relationship between oral corticosteroid (OCS) exposure and the long-term risk of cataract.
Method: Following PRISMA guidelines, a systematic review and meta-analysis were conducted to investigate this association. Relevant studies were identified through comprehensive searches across multiple databases. Data included cataract incidence/prevalence and OCS therapy.
Results: A total of 1,270 articles were retrieved from online databases (PubMed, SagePub, SpringerLink and Google Scholar). After three rounds of screening, five articles directly relevant to the systematic review were selected for full-text reading and analysis. These five studies collectively involved 27,250 cases of cataract following oral corticosteroid (OCS) exposure, while 47,267 controls did not develop cataracts. No statistically significant association is found between OCS and cataract formation (OR 0.117, CI 95 0.0085 to 1.6021, p0.11).
Conclusion: Cataracts in oral corticosteroid (OCS) users result from abnormal lens cell movement and protein composition changes due to protein adduct formation. Increased OCS dosage and frequency correlate with higher cataract risk. However, evidence quality was deemed low to moderate, highlighting the need for well-designed RCTs to minimize bias and heterogeneity.
References
Liu YC, Wilkins M, Kim T, Malyugin B, Mehta JS. Cataracts. The Lancet [Internet]. 2017 Aug 5 [cited 2024 Feb 24];390(10094):600–12. Available from: https://www.thelancet.com/article/S0140-6736(17)30544-5/abstract
Deng R, Zhu Z, Han X, Shang X, He M, Xu G, et al. Evaluation of Systemic Medications Associated With Surgically Treated Cataract Among US Adults. American Journal of Ophthalmology [Internet]. 2023 May 1 [cited 2024 Feb 24];249:126–36. Available from: https://www.sciencedirect.com/science/article/pii/S0002939423000107
Alderaan K, Sekicki V, Magder LS, Petri M. Risk factors for cataracts in systemic lupus erythematosus (SLE). Rheumatol Int [Internet]. 2015 Apr 1 [cited 2024 Feb 23];35(4):701–8. Available from: https://doi.org/10.1007/s00296-014-3129-5
Nath T, Roy S, Kumar H. Prevalence of Steroid-Induced Cataract and Glaucoma in Chronic Obstructive Pulmonary Disease Patients Attending a Tertiary Care Center in India. Asia Pac J Ophthalmol (Phila) [Internet]. 2017 [cited 2024 Feb 24]; Available from: https://journals.lww.com/apjoo/Abstract/2017/01000/Prevalence_of_Steroid_Induced_Cataract_and.7.aspx
Bloechliger M, Reinau D, Spoendlin J, Chang SC, Kuhlbusch K, Heaney LG, et al. Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis. Respir Res. 2018 Apr 27;19(1):75.
Gaur S, Joseph M, Nityanandam S, Subramanian S, Koshy AS, Vasudevan A, et al. Ocular Complications in Children with Nephrotic Syndrome on Long Term Oral Steroids. Indian J Pediatr [Internet]. 2014 Jul 1 [cited 2024 Feb 24];81(7):680–3. Available from: https://doi.org/10.1007/s12098-014-1338-2
Minkus CL, Pistilli M, Dreger KA, Fitzgerald TD, Payal AR, Begum H, et al. Risk of Cataract in Intermediate Uveitis. American Journal of Ophthalmology [Internet]. 2021 Sep 1 [cited 2024 Feb 24];229:200–9. Available from: https://www.sciencedirect.com/science/article/pii/S0002939421001021
Shabbir K, Anjum M, Naeem B, Urooj H. Frequency of posterior cataract in steroid-dependent or frequent relapse nephrotic syndrome in children. The Professional Medical Journal [Internet]. 2023 Nov 1 [cited 2024 Feb 24];30(11):1436–41. Available from: https://www.theprofesional.com/index.php/tpmj/article/view/7726
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Yovita, Bambang Setiohadji
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
